SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1for'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K5Q_B_PACB559_0
(PENICILLIN G ACYLASE
ALPHA SUBUNIT
PENICILLIN G ACYLASE
BETA SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 SER H 208
PRO H 206
ALA H 204
ALA H 124
None
1.01A 1k5qA-1forH:
undetectable
1k5qB-1forH:
undetectable
1k5qA-1forH:
19.31
1k5qB-1forH:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_A_CLMA1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.70A 1usqA-1forH:
0.0
1usqA-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_B_CLMB1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.69A 1usqB-1forH:
0.0
1usqB-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_C_CLMC1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.70A 1usqC-1forH:
0.0
1usqC-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_D_CLMD1142_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.71A 1usqD-1forH:
0.0
1usqD-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_E_CLME1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.70A 1usqE-1forH:
0.0
1usqE-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_F_CLMF1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.69A 1usqF-1forH:
0.0
1usqF-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_A_CLMA1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.76A 2jkjA-1forH:
0.0
2jkjA-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_B_CLMB1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.76A 2jkjB-1forH:
0.0
2jkjB-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_C_CLMC1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.76A 2jkjC-1forH:
0.0
2jkjC-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_E_CLME1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.75A 2jkjE-1forH:
0.0
2jkjE-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_A_CLMA1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.75A 2jklA-1forH:
0.0
2jklA-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_B_CLMB1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.76A 2jklB-1forH:
0.0
2jklB-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_C_CLMC1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.75A 2jklC-1forH:
0.0
2jklC-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_D_CLMD1145_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.75A 2jklD-1forH:
0.0
2jklD-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_E_CLME1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.75A 2jklE-1forH:
0.0
2jklE-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_F_CLMF1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
4 / 7 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.76A 2jklF-1forH:
0.0
2jklF-1forH:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MG0_K_BO2K1402_1
(PROTEASOME COMPONENT
PRE2
PROTEASOME COMPONENT
C5)
1for IGG2A-KAPPA 17-IA
FAB (HEAVY CHAIN)

(Mus
musculus)
5 / 11 ALA H  79
ALA H  72
VAL H  34
ALA H  24
SER H   7
None
0.90A 3mg0K-1forH:
0.0
3mg0L-1forH:
0.0
3mg0K-1forH:
21.12
3mg0L-1forH:
20.73